Common genetic variation associated with Mendelian disease severity revealed through cryptic phenotype analysis

Area of Science:

• Genetics
• Computational Biology
• Medical Research

Background:

• Mendelian diseases exhibit clinical heterogeneity, making genetic factor identification challenging due to small sample sizes.
• Analyzing the full spectrum of phenotypic variation, including severe cases, can increase statistical power to detect modifier effects.

Purpose of the Study:

• To develop and validate a novel method, cryptic phenotype analysis, for inferring quantitative traits from qualitative symptom data in Mendelian diseases.
• To identify genetic variants associated with Mendelian disease severity and outcomes using large-scale cohorts.

Main Methods:

• Developed cryptic phenotype analysis, a model-based approach to infer quantitative traits reflecting disease variability from qualitative symptom data.
• Applied the method to 50 Mendelian diseases across two cohorts to quantify disease severity.
• Conducted genome-wide association studies (GWAS) on five inferred cryptic phenotypes.

Main Results:

• Successfully identified quantitative traits that reliably measure disease severity across various Mendelian conditions.
• Uncovered common genetic variations predictive of Mendelian disease diagnoses and clinical outcomes.
• Demonstrated the utility of computationally derived phenotypes in large biobank-scale cohorts.

Conclusions:

• Cryptic phenotype analysis is a powerful tool for dissecting the genetic architecture of Mendelian diseases.
• Leveraging large cohorts and computational phenotypes enhances the ability to identify genetic modifiers of disease.
• This approach offers new avenues for understanding disease variability and improving patient outcomes.